2) The high expressions of CBX2/3/5/6 were associated with worser OS in DLBCL patients, and multivariate COX regression analysis showed that the expression level of CBX3 could predict the patients prognosis together with other clinical variables (e.g., age, gender, pathological type, ECOG score, extranodal metastasis, LDH ratio) . This evidence concerns the gene CBX2 and diffuse large B-cell lymphoma.